Regulatory Genome Development Ltd
12862325
Some Concerns
- Negative net worth (-10)
- Loss before tax (-10)
- Current liabilities exceed current assets (-10)
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
director · Since 17/12/2020
COMPANY DIRECTOR
BRITISH · UNITED KINGDOM · Age 68
director · Since 18/11/2021
MANAGING PARTNER
AMERICAN · SWITZERLAND · Age 60
Persons with Significant Control
Former PSCs
Mr Robert Hugh Wardrop
Ceased 21/12/2020
Charges0 outstanding
ROBERT WARDROP
CompanyRankvs 56232+ SIC 62012 peers30
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/12/2024
Turnover
£161k
Annual revenue
Net Worth
-£8.5M
Balance sheet strength
Cash
£154k
Cash in the bank
Profit Before Tax
-£4.3M
Bottom line earnings
Net Current Assets
-£133k
Working capital
Current Assets
£375k
Current Liabilities
£508k
Fixed Assets
£93k
Debtors
£221k
Gross Profit
£161k
Admin Expenses
£4.1M
Operating Profit
-£4.0M
Profit After Tax
-£4.2M
Director Loans(2021)
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2024 | 0.74 | -£4.2M |
| 2023 | 6.78 | — |
| 2022 | 1.72 | — |
| 2021 | 11.25 | — |
Derived from filed accounts. Not audited figures.